1. Introduction
Lower extremity peripheral arterial disease (PAD) is increasingly acknowledged as a significant public health concern affecting approximately 12% to 14% of the general population, with the prevalence escalating to nearly 30% in individuals over 50 years of age [
1]. PAD is closely associated with increased risks of cardiovascular diseases and a higher overall mortality. Notably, the 5-year mortality associated with chronic limb-threatening ischemia without amputation is estimated at 55–65%, exceeding the mortality rates of many cancers [
2,
3]. PAD manifests as systemic atherosclerosis, characterized by stenosis or occlusion in the peripheral arterial vasculature of the lower limbs, leading to symptoms such as intermittent claudication, ischemic rest pain, and a progressive decline in functional capacity—indicative of compromised blood flow and tissue ischemia [
4].
At the core of the atherosclerotic processes in the lower limbs is also a vascular inflammation process, in which the visceral adipose tissue plays a significant role, as already demonstrated in coronary artery disease [
5,
6]. Indeed, the visceral adipose tissue impacts vascular homeostasis by releasing factors that influence the layers of the smooth muscle cells, thereby regulating the vascular tone, blood flow distribution, angiogenesis, and inflammatory processes [
7]. In fact, as already reported in the literature [
8], there is a positive correlation between the perivascular attenuation levels of the perivascular adipose tissue (PVAT) measured in the CTA and the adjacent plaque, supporting a direct bilateral influence [
6,
9,
10,
11,
12,
13,
14,
15,
16].
Although increased PVAT density is associated with coronary artery disease and high-risk vulnerable plaques, this association has not yet been evaluated in the lower limb peripheral arteries. Therefore, the purpose of this study was to investigate the association between the grades of lower limb peripheral arterial stenosis and vascular adipose tissue density at CTA.
2. Materials and Methods
2.1. Study Population
This retrospective study received approval from the local Ethics Committee. It was funded by the local research resources of CDI Centro Diagnostico Italiano S.p.A. (Milan, Italy), a clinical diagnostic center. Given its retrospective design, obtaining specific informed consent from the participants was deemed unnecessary.
The study involved a retrospective evaluation of a consecutive cohort of patients of both genders, diagnosed with PAD, who had previously undergone CTA. The criteria for exclusion included patients who had undergone a surgical bypass and those who had already received surgical treatment for PAD.
2.2. Images Acquisition
The computed tomography angiography (CTA) procedures were conducted using a 64-slice CT scanner (SOMATOM Definition AS, Siemens Healthcare GmbH, Erlangen, Germany, EU). This was in alignment with the specific clinical requirements of each case. The patient positioning involved a supine, feet-first orientation.
The scanner’s beam collimation was set at 64 × 0.625 mm, with a tube voltage of 120 kVp. An automatic tube current modulation feature was activated, allowing a range between 90 and 330 mA. The scanning volume encompassed an area extending from the T12 vertebral level down to the feet. For the image reconstruction, a standard kernel was used, producing images with a slice thickness of 1.25 mm. For the contrast CT, a bolus of Iopamiro 370 mg/mL (Bracco Imaging S.p.A., Milan, Italy) was injected with a flow of 5 mL/s using a CT Exprès® injector (Bracco Imaging S.p.A., Via E. Folli 50, Milan, Italy).
2.3. Image Analyses
In this study, five key arterial segments in both legs of each patient were assessed: the common iliac (CI), external iliac (EI), common femoral (CF), superficial femoral (SF), and popliteal arteries (POP).
The degree of arterial stenosis was categorized into four distinct classes: <25%, 25–50%, 50–70%, and >70%. Perivascular adipose tissue (PVAT) density, measured in Hounsfield Units (HU), was determined by positioning a 5 mm circular region of interest (ROI) adjacent to the vascular wall, as shown in
Figure 1 and
Figure 2. Additionally, for each of these vascular segments, both the degree of stenosis and the corresponding PVAT attenuation values were quantitatively assessed.
2.4. Statistical Analysis
We assessed the normality of the continuous data using the Shapiro–Wilk test. Data conforming to a normal distribution were reported as mean ± standard deviation (SD), while non-normal data were described using the median and inter-quartile range (IQR).
PVAT density was quantified through the region of interest (ROI) placements by two evaluators in a blinded manner, and the inter-rater reproducibility was gauged using the coefficient of reproducibility (CoR). Given that reproducibility ranged from 75% to 83%, we utilized the mean of the measurements from both readers for the statistical analysis.
To investigate the relationship between the average PVAT density and various degrees of stenosis, we applied the Kruskal–Wallis test to identify the group differences. This was supplemented by the pairwise Mann–Whitney U test with the Holm–Bonferroni correction for more detailed comparisons, with adjusted p-values provided to enhance clarity.
Statistical analyses were performed using SPSS for Windows, version 21.0 (SPSS Inc., Chicago, IL, USA), and Microsoft Excel 2010 (Redmond, WA, USA). We established a p-value threshold of less than 0.05 to determine the statistical significance.
3. Results
3.1. Population Analysis
In accordance with the defined exclusion criteria, a select cohort of consecutive 53 patients was identified and analyzed. The cohort had a median age of 69 (IQR 60–78; max 89, min 46) years. Among these patients, 34 (64%) were men with a median age of 69 (IQR 62–78; max 89, min 46) years and 19 (36%) were women with a median age of 68 (IQR 54–79; min 50, max 87) years.
For each patient, two resident radiologists conducted blind evaluations on both legs, specifically assessing the five key arterial segments mentioned above (see
Section 2). The reproducibility between the readers was assessed using the CoR; however, in order to use a more robust value for the statistical analysis, the mean value of both readers’ measures was used. The CoR for each artery is summarized in
Table 1. In each of these arterial segments, they quantified the degree of stenosis and measured the PVAT density summarized in
Table 2,
Table 3 and
Table 4.
3.2. Artery Analysis
A correlation among all the arteries and the PVAT, using the Kruskal–Wallis test, a statistically significant difference was found (
p < 0.001) among the groups categorized by the degree of stenosis, concerning PVAT density. Using the pairwise Mann–Whitney U test, a statistically significant difference was found between the groups categorized by the degrees of <25% and 25–50% of stenosis (adjusted
p < 0.001), between the groups categorized by the degrees of <25% and 50–75% of stenosis (adjusted
p < 0.001), between the groups categorized by the degrees of <25% and >75% of stenosis (adjusted
p < 0.001), and between the groups categorized by the degrees of 25–50% and >75% (adjusted
p = 0.002). The same analysis was performed among all the arteries of each side (right and left). More details are summarized in
Table 2,
Table 3 and
Table 4.
3.3. Common Iliac Artery
For the CI artery, the median PVAT density was −89 HU (IQR −96 to −82), and using the Kruskal–Wallis test, a non-significant difference was found (p = 0.102) among the groups categorized by the degree of stenosis, concerning PVAT density.
For the left CI artery, the median PVAT density was −91 HU (IQR −96 to −82), while in terms of stenosis, the distribution within the 53-patient cohort was as follows: 17 patients (33%) exhibited <25% of stenosis; 22 patients (43%) had a stenosis of between 25% and 50%; 12 patients (23%) had a stenosis ranging from 50% to 75%; and 2 patients (4%) had a stenosis of >75%. Using the Kruskal–Wallis test, a non-significant difference was found (p = 0.349) among the groups categorized by the degree of stenosis, concerning PVAT density.
For the right CI artery, the median PVAT density was −92 HU (IQR −97 to −84), while in terms of stenosis, the distribution within the 53-patient cohort was as follows: 17 patients (32%) exhibited <25% of stenosis; 29 patients (55%) had a stenosis of between 25% and 50%; 5 patients (9%) showed a stenosis ranging from 50% to 75%; and 2 patients (4%) had a stenosis of >75%. Using the Kruskal–Wallis test, a non-significant difference was found (
p = 0.300) among the groups categorized by the degree of stenosis, concerning PVAT density (further details are shown in
Table 2,
Table 3 and
Table 4).
3.4. External Iliac Artery
For the EI artery, the median PVAT density was −90 HU (IQR −97 to −80), and using the Kruskal–Wallis test, a statistically significant difference was found (p = 0.003) among the groups categorized by the degree of stenosis, concerning PVAT density. Using the pairwise Mann–Whitney U test, a statistically significant difference was found between the groups categorized by the degrees of <25% of stenosis and 25–50% of stenosis (adjusted p = 0.043), and between <25% of stenosis and 50–75% of stenosis (adjusted p = 0.017).
For the left EI artery, the median PVAT density was −91 HU (IQR −99 to −84), while in terms of stenosis, the distribution within the 53-patient cohort was as follows: 33 patients (62%) exhibited less than 25% of stenosis; 14 patients (26%) had a stenosis between 25% and 50%; 1 patient (2%) had a stenosis of between 50% and 75%; 5 out of 53 (9%) had a stenosis of >75%. Using the Kruskal–Wallis test, a statistically significant difference was found (p = 0.011) among the groups categorized by the degree of stenosis, concerning PVAT density. In particular, the pairwise Mann–Whitney U test found a statistically significant difference (adjusted p = 0.041) between the groups categorized by the degrees of <25% of stenosis and 25–50% of stenosis, concerning PVAT density.
For the right EI artery, the median PVAT density was −90 HU (IQR −97 to −85), and while in terms of stenosis, the distribution within the 53-patient cohort was as follows: 31 out of 53 (58%) patients had less than 25% of stenosis; 16 out of 53 (30%) patients had a stenosis of between 25% and 50%; 2 out of 53 (4%) had a stenosis of between 50% and 75%; 4 out of 53 (8%) had a stenosis of >75%. Using the Kruskal–Wallis test, a statistically no-significant difference was revealed (p = 0.107) among the groups categorized by the degree of stenosis, concerning PVAT density.
3.5. Common Femoral Artery
For the CF artery, the median PVAT density was −87 HU (IQR −94 to −78), and using the Kruskal–Wallis test, a statistically significant difference was revealed (p = 0.020) among the groups categorized by the degree of stenosis, concerning PVAT density. Using the pairwise Mann–Whitney U test, a statistically significant difference was found (adjusted p = 0.020) between the groups categorized by the degrees of <25% of stenosis and 25–50% of stenosis, concerning PVAT density.
For the left CF artery, the median PVAT density was −87 HU (IQR −94 to −80), while in terms of stenosis, the distribution within the 53-patient cohort was as follows: 23 out of 53 (43%) patients had less than 25% of stenosis; 24 out of 53 (45%) had a stenosis of between 25% and 50%; 3 out of 53 (6%) had a stenosis between 50% and 75%; 3 out of 53 (6%) had a stenosis of >75%. Using the Kruskal–Wallis test, a statistically non-significant difference was revealed (p = 0.058) among the groups categorized by the degree of stenosis, concerning PVAT density.
For the right CF artery, the median PVAT density was −89 HU (IQR −94 to −84), while in terms of stenosis, the distribution within the 53-patient cohort was as follows: 23 out of 53 (43%) patients had less than 25% of stenosis; 26 out of 53 (49%) had a stenosis of between 25% and 50%; 1 out of 53 (2%) had a stenosis of between 50% and 75%; 3 out of 53 (6%) had a stenosis of >75%. Using the Kruskal–Wallis test, a statistically non-significant difference was revealed (p = 0.372) among the groups categorized by the degree of stenosis, concerning PVAT density.
3.6. Superficial Femoral Artery
For the SF artery, the median PVAT density was −88 HU (IQR −96 to −78), and using the Kruskal–Wallis test, a statistically significant difference was found (p <0.001) among the groups categorized by the degree of stenosis, concerning PVAT density. Using the pairwise Mann–Whitney U test, a statistically significant difference was found between the groups, categorized by the degrees of <25% of stenosis and >75% of stenosis (adjusted p < 0.001), and between 25% and 50% of stenosis and >75% of stenosis (adjusted p = 0.010).
For the left SF artery, the median PVAT density was −90 HU (IQR −96 to −80), while in terms of stenosis, the distribution within the 53-patient cohort was as follows: 21 out of 53 (40%) patients had less than 25% of stenosis; 16 out of 53 (30%) patients had a stenosis of between 25% and 50%; 3 out of 53 (6%) had a stenosis of between 50% and 75%; 13 out of 53 (25%) had a stenosis of >75%. Using the Kruskal–Wallis test, a statistically significant difference was found (p = 0.032) among the groups categorized by the degree of stenosis, concerning PVAT density. Using the pairwise Mann–Whitney U test, a statistically significant difference was found (adjusted p = 0.027) between the groups, categorized by the degrees of <25% of stenosis and >75% of stenosis, concerning PVAT density.
For the right SF artery, the median PVAT density was −89 HU (IQR −96 to −82), while in terms of stenosis, the distribution within the 53-patient cohort was as follows: 20 out of 53 (38%) patients had less than 25% of stenosis; 14 out of 53 (26%) patients had a stenosis of between 25% and 50%; 6 out of 53 (11%) had a stenosis of between 50% and 75%; 13 out of 53 (25%) had a stenosis of >75%. Using the Kruskal–Wallis test, a statistically significant difference was found (p = 0.002) among the groups categorized by the degree of stenosis, concerning PVAT density. Using the pairwise Mann–Whitney U test, a statistically significant difference was found between the groups categorized by the degrees of <25% of stenosis and >75% of stenosis (adjusted p = 0.002), and between 25% and 50% of stenosis and >75% of stenosis (adjusted p = 0.038).
3.7. Popliteal Femoral Artery
For the POP artery, the median PVAT density was −96 HU (IQR −103 to −89), and using the Kruskal–Wallis test, a statistically significant difference was found (p <0.001) among the groups categorized by the degree of stenosis, concerning PVAT density. Using the pairwise Mann–Whitney U test, a statistically significant difference was found (adjusted p = 0.004) between the groups categorized by the degrees of <25% stenosis and >75% stenosis, concerning PVAT density.
For the left POP artery, the median PVAT density was −97 HU (IQR −107 to −94), while in terms of stenosis, the distribution within the 53-patient cohort was as follows: 32 out of 53 (60%) patients had less than 25% stenosis; 13 out of 53 (25%) patients had a stenosis between 25% and 50%; 2 out of 53 (4%) had a stenosis between 50% and 75%; 6 out of 53 (11%) had a stenosis of >75%. Using the Kruskal–Wallis test, a statistically significant difference was found (p = 0.019) among the groups categorized by the degree of stenosis, concerning PVAT density.
For the right POP artery, the median PVAT density was −96 HU (IQR −103 to −89), while in terms of stenosis, the distribution within the 53-patient cohort was as follows: 29 out of 53 (55%) patients had less than 25% stenosis; 15 out of 53 (28%) patients had a stenosis between 25% and 50%; 3 out of 54 (6%) had a stenosis between 50% and 75%; 6 out of 53 (11%) had a stenosis of >75%. Using the Kruskal–Wallis test, a statistically significant difference was found (p = 0.013) among the groups categorized by the degree of stenosis, concerning PVAT density.
4. Discussion
In the current study, we evaluated a cohort of 53 consecutive patients who had undergone a CTA; the cohort was predominantly male (64%), with a median age of 69 years. Our aim was to explore the utility of PVAT density as an imaging biomarker [
11] for assessing disease severity in peripheral arteries, based on the hypothesis that increased PVAT density correlates with a higher degree of stenosis. These findings are summarized in
Table 1,
Table 2,
Table 3 and
Table 4.
Among all the imaging modalities that could have been implemented, at the net of the advantages and disadvantages we decided to use CT as the modality of choice, supported by the study of R. Met et al. and M. Heijenbrok et al. [
17,
18], which highlighted the accuracy of the CT scan in the assessment of PAD in all regions of the lower extremity arteries. In fact, where CT allows the detection and evaluation of arterial stenosis, calcification, and plaque morphology, MRI lacks in the ability to determine calcifications, which is an element of particular interest in the PAD risk stratification.
Notably, we found a positive association between increased PVAT density and the degree of arterial stenosis, particularly in the left external iliac, superficial femoral, and popliteal arteries. This association aligned with the observations by Han et al. [
13], who reported a similar distribution of disease, notably within the femoral artery segment, underscoring the potential of PVAT density as a marker of disease severity in PAD. Moreover, a more prominent correlation between the stenosis degree and PVAT density among the more distal arteries was found. Since these arterial vessels are thinner, among the arterial bundle considered in our study, the perivascular adipose tissue is more likely to induce a higher inflammatory condition proportionally.
In accordance with this, the CRISP study by Oikonomou et al. established a compelling link between perivascular adipose tissue (PVAT) inflammation in coronary arteries and an increased risk of atherosclerotic plaque rupture. This association underscored the importance of identifying high-risk patients for potential intervention with more intensive therapeutic strategies [
9]. The significance of these findings was further corroborated using a histopathological examination, where lesions at a high risk of rupture demonstrated active inflammation, emphasizing the role of PVAT in cardiovascular risk stratification [
7].
Aside from the histopathological examination, there are different humoral factors that have been identified as potential biomarkers for PAD severity assessment. In fact, X. Wang et al. [
19,
20] underlined how these factors, within CT angiography, can provide information about vascular and plaque calcification, which is crucial for risk stratification in PAD. In particular, they highlighted the elevated serum concentration of vascular endothelial growth factor C (VEGF-C) and interleukin-6 (IL-6) in patients with moderate/severe peripheral artery stenosis, aside from matrix metalloproteinases (MMPs) and lipoprotein-associated phospholipase A2 (Lp-PLA2).
Indeed, atherosclerosis is recognized as a systemic inflammatory condition, suggesting that its manifestations are not confined to a single vascular arterial vessel. This systemic nature is evident in patients with peripheral artery disease (PAD), who exhibit more extensive coronary atherosclerosis, highlighting the interconnectedness of vascular pathology across different regions [
10,
12].
Despite these promising results, our study encountered significant limitations, primarily due to its retrospective design, which may have introduced biases by relying on previously collected data, potentially affecting the robustness of our findings. Additionally, the relatively small sample size limited the generalizability of our results, as it may not have adequately represented the broader population affected by PAD, thereby constraining the statistical power to detect significant associations. Furthermore, the measurement of PVAT density was subjected to variability due to the manual placement of a 5 mm ROI adjacent to the vascular wall, introducing an element of operator dependency. Future research could benefit from adopting more objective methods, like the Fat Attenuation Index (FAI) used by Oikonomou et al. [
9], to enhance measurement accuracy and reproducibility.
However, to our knowledge, this is the first study to correlate PVAT density with the severity of stenosis in patients with PAD. Given the substantial impact of PAD on mortality and morbidity, our findings offer a promising avenue for future large-scale studies, utilizing the FAI to validate PVAT density as a reliable biomarker of disease severity. Such research could pave the way for novel diagnostic and therapeutic strategies in managing PAD, ultimately improving patient outcomes.